Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 38.27% vs 35.60% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 107.22% vs 49.77% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "474.00",
          "val2": "342.80",
          "chgp": "38.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "211.20",
          "val2": "115.30",
          "chgp": "83.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.30",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "9.50",
          "val2": "4.30",
          "chgp": "120.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "203.90",
          "val2": "98.40",
          "chgp": "107.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "445.60%",
          "val2": "244.50%",
          "chgp": "20.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.75% vs 23.37% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 143.97% vs 524.23% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,190.20",
          "val2": "1,010.80",
          "chgp": "17.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "334.50",
          "val2": "287.30",
          "chgp": "16.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.40",
          "val2": "1.60",
          "chgp": "-12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "28.90",
          "val2": "19.40",
          "chgp": "48.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "691.40",
          "val2": "283.40",
          "chgp": "143.97%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "173.60%",
          "val2": "189.20%",
          "chgp": "-1.56%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY

Sep'25

Sep'24

Change(%)

Net Sales

474.00

342.80

38.27%

Operating Profit (PBDIT) excl Other Income

211.20

115.30

83.17%

Interest

0.00

0.30

-100.00%

Exceptional Items

9.50

4.30

120.93%

Consolidate Net Profit

203.90

98.40

107.22%

Operating Profit Margin (Excl OI)

445.60%

244.50%

20.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Sep 2025 is 38.27% vs 35.60% in Sep 2024

Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 107.22% vs 49.77% in Sep 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,190.20

1,010.80

17.75%

Operating Profit (PBDIT) excl Other Income

334.50

287.30

16.43%

Interest

1.40

1.60

-12.50%

Exceptional Items

28.90

19.40

48.97%

Consolidate Net Profit

691.40

283.40

143.97%

Operating Profit Margin (Excl OI)

173.60%

189.20%

-1.56%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 17.75% vs 23.37% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 143.97% vs 524.23% in Dec 2023

All Annual Results